期刊文献+

高血压患者长期口服二氢吡啶类药物对维库溴铵肌松效应的影响 被引量:2

Effects of long-term taking dihydropyridines on neuromuscular blockade of vecuronium in patients with hypertension
暂未订购
导出
摘要 目的观察高血压患者长期口服二氢吡啶类药物对维库溴铵的肌松效应的影响。方法选择长期口服(超过3个月)珍菊降压片或二氢吡啶类药的高血压患者行中下腹部手术各30例,ASAⅠ或Ⅱ级,分为两组:长期口服二氢吡啶类药组(观察组)和长期口服珍菊降压片组(对照组)。用肌松监测仪观察并记录两组患者术中维库溴铵的起效时间(T1消失)、T1出现时间、TOF出现时间、T1恢复至25%的时间及恢复指数。结果两组患者术中维库溴铵的起效时间、作用持续时间和恢复指数差异均无统计学意义。结论高血压患者长期使用二氢吡啶类药物对维库溴铵肌松效应无显著影响。 Objective To investigate the effects of long-term taking dihydropyridines (over three months) on neuromuscular blockade of vecuronium in patients with hypertension. Methods Sixty ASA class Ⅰ or Ⅱ patients undergoing abdomen surgery were divided into two groups with 30 cases each. Control group received zhenju antihypertension tablet orally for more than 3 months,while study group was administered dihydropyridines. The onset time (T1 disappeared), duration,the time of TOF appeared, the time when T1 returned to 25 % and recovery index of vecuronium were monitored with a peripheral nerve stimulator. Results There were no significant differences in onset time,duration and recovery index between the two groups. Conclusion Dihydropyridines taken for more than 3 months in patients with hypertension have no significant effect on the efficacy of vecuronium.
出处 《临床麻醉学杂志》 CAS CSCD 2007年第6期457-459,共3页 Journal of Clinical Anesthesiology
关键词 二氢吡啶类药 神经肌肉阻滞 维库溴铵 Dihydropyridines Neuromuscular block Vecuronium
  • 相关文献

参考文献8

  • 1孟舒献,温晓娜.二氢吡啶类钙通道阻滞剂的研究进展[J].广东药学院学报,2004,20(2):170-172. 被引量:24
  • 2肖艳萍,孙忠实.钙通道阻滞剂的临床应用评价[J].中国医院用药评价与分析,2003,3(1):11-14. 被引量:10
  • 3徐世元,刘辉.神经肌肉传递功能监测.临床监测学.北京:人民卫生出版社,2005.586-607.
  • 4Mizuguchi KA,Takakuwa Y,hoh E,et al.Membrane fusion of erythrocytes as a model study of the effects of muscle relaxants on presynaptic exocytosis.Anesth Analg,1994,78:1077-1082.
  • 5庄心良,曾因明,陈伯銮.神经肌肉兴奋传递.现代麻醉学.北京:人民卫生出版社,2003.562-589.
  • 6唐树德.钙通道阻滞剂的临床应用[J].上海医药,2001,22(1):25-26. 被引量:2
  • 7庄心良 见:庄心良 曾因明 陈伯銮 主编.肌松药[A].见:庄心良,曾因明,陈伯銮,主编.现代麻醉学.第3版[C].北京:人民卫生出版社,2003.571-575.
  • 8Aysel I,Hepaguslar H,Balcioglu T,et al.The effects of nimodipine on vecuronium-induced neuromuscular blockade.Eur J Anaesthesiol,2000,17:383-389.

二级参考文献39

  • 1陶萍.硝苯地平控释片的制剂特点[J].中华心血管病杂志,1994,22(5):326-327. 被引量:20
  • 2顾复生.硝苯地平控释片的临床应用进展[J].中华心血管病杂志,1994,22(5):327-328. 被引量:33
  • 3陈达光.钙拮抗剂降压治疗远期效果的争议[J].中华心血管病杂志,1996,24(3):167-168. 被引量:21
  • 4戴玉华 余国膺.1995年关于钙拮抗剂的一场争论[J].医学进展,1996,1(2):3-3.
  • 5[1]Mancia G, Grassi G. Antihypertensive treatment:past, present and future. J Hypertens,1998,16(1):S1.
  • 6[2]Ferrari R. Major difference among the three classes of calcium antagonists. Eur Heart J, 1997,18 (Suppl A) :A56.
  • 7[3]Godfraind T. Cardioselectivety of Calcium Channel Blocker. Cariovasc Drugs Ther, 1994,11 (8): 353.
  • 8[4]Furberg CD,Pesaty BM, Meyer JV, et al. Nifedipine dose-refated increase in mortality in patients with coronary heart disease. Circulation, 1995,92 (3):1326.
  • 9[5]Tang SD, Gong LS, Ming ZL, et al. Nifedipine GITS therapy for hypertension after transplantation. J Hypertens, 1997, 15(Suppl. 4): 201.
  • 10[6]Dreyer EB, Kaiser PK, Offermann JJ ,et al. HIV-1 Coat protein nearotoxicity prevented by calciam channel antagonists. Science,1990,68(248) :364.

共引文献38

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部